UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Annals of oncology, 2009-09, Vol.20 (9), p.1596-1603

2009

Link zum Volltext

Verfügbarkeit prüfen

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Annals of oncology, 2018-11, Vol.29 (11), p.2163-2174

2018

Link zum Volltext

Verfügbarkeit prüfen

Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis

Annals of oncology, 2024-03, Vol.35 (3), p.317-326

2024

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life in patients with melanoma expressed as utilities and disability weights

British journal of dermatology (1951), 2014-12, Vol.171 (6), p.1443-1450

2014

Link zum Volltext

Verfügbarkeit prüfen

Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors

Annals of oncology, 2024-02, Vol.35 (2), p.221-228

2024

Link zum Volltext

Verfügbarkeit prüfen

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Annals of oncology, 2014-03, Vol.25 (3), p.742-746

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

BMC cancer, 2021-05, Vol.21 (1), p.578-578, Article 578

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery

European journal of cancer (1990), 2014-09, Vol.50 (14), p.2408-2416

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

Annals of oncology, 2005-12, Vol.16 (12), p.1898-1905

2005

Link zum Volltext

Verfügbarkeit prüfen

Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study

British journal of dermatology (1951), 2012-10, Vol.167 (4), p.778-786

2012

Link zum Volltext

Verfügbarkeit prüfen

Auto-immune gastritis induced by pembrolizumab, an anti-PD-1, in a melanoma patient

Acta gastro-enterologica belgica, 2020-07, Vol.83 (3), p.482-484

2020

Link zum Volltext

Verfügbarkeit prüfen

Loss of HLA class I expression and T-cell infiltration or PD-L1 expression are associated with different response patterns to pembrolizumab in melanoma

Annals of oncology, 2018-10, Vol.29, p.viii450-viii450

2018

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient

Acta gastro-enterologica belgica, 2023-04, Vol.86 (2), p.371-373

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

ESMO open, 2023-04, Vol.8 (2), p.100884-100884, Article 100884

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

Breast cancer research and treatment, 2011-06, Vol.127 (3), p.689-696

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment algorithm in patients with ovarian cancer

Facts, views & vision in ObGyn, 2020-10, Vol.12 (3), p.227-239

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

Immunity (Cambridge, Mass.), 1997-02, Vol.6 (2), p.199-208

1997

Link zum Volltext

Verfügbarkeit prüfen

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

Facts, views & vision in ObGyn, 2016-09, Vol.8 (3), p.161-167

2016

Link zum Volltext

Verfügbarkeit prüfen

Unusual pulmonary toxicity of ipilimumab treated by macrolides

Acta clinica belgica (English ed. Online), 2015-12, Vol.70 (6), p.442-444

2015

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Journal of the European Academy of Dermatology and Venereology, 2020-09, Vol.34 (9), p.1876-1878

2020

Link zum Volltext

Verfügbarkeit prüfen

A point mutation in the α-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.4078-4083

2001

Link zum Volltext

Verfügbarkeit prüfen

EP909 Influence of intraoperative administration of ketorolac on the prognosis of ovarian cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A489-A489

2019

Link zum Volltext

Verfügbarkeit prüfen

EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPIES FOR SOLID TUMOURS

Acta clinica belgica (English ed. Online), 2011-01, Vol.66 (1), p.10-17

2011

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor targeted therapies for solid tumours

Acta clinica belgica (English ed. Online), 2011-01, Vol.66 (1), p.10-17

2011

Link zum Volltext

Verfügbarkeit prüfen

O013/#573 Tisotumab vedotin (TV) + bevacizumab or pembrolizumab or carboplatin in recurrent/metastatic cervical cancer (R/MCC): phase 1B/2 engot-CX8/GOG-3024/innovaTV 205 study dose-escalation results

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A7-A8

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(53)
Humans
(45)
Oncology
(31)
Middle Aged
(24)
Adult
(23)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Female
(19)
Aged
(18)
Male
(16)
Tumors
(12)
Pharmacology. Drug Treatments
(11)
Chemotherapy
(9)
Adolescent
(8)
General & Internal Medicine
(8)
Metastasis
(8)
T-Lymphocytes, Cytotoxic - Immunology
(8)
Aged, 80 And Over
(7)
Antineoplastic Agents
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis

Health-related quality of life in patients with melanoma expressed as utilities and disability weights

Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study

Auto-immune gastritis induced by pembrolizumab, an anti-PD-1, in a melanoma patient

Loss of HLA class I expression and T-cell infiltration or PD-L1 expression are associated with different response patterns to pembrolizumab in melanoma

Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

Treatment algorithm in patients with ovarian cancer

Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

Unusual pulmonary toxicity of ipilimumab treated by macrolides

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

A point mutation in the α-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma

EP909 Influence of intraoperative administration of ketorolac on the prognosis of ovarian cancer

EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPIES FOR SOLID TUMOURS

Epidermal growth factor receptor targeted therapies for solid tumours

O013/#573 Tisotumab vedotin (TV) + bevacizumab or pembrolizumab or carboplatin in recurrent/metastatic cervical cancer (R/MCC): phase 1B/2 engot-CX8/GOG-3024/innovaTV 205 study dose-escalation results

Suchergebnisse filtern